Skip to main content

Acute Mountain Sickness

3
Pipeline Programs
4
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
ErythropoietinPhase 41 trial
Active Trials
NCT05734716Completed121Est. Jan 2023
Autonomous Therapeutics
1 program
1
Suxiao Jiuxin PillPhase 2/3
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
1
Prochlorperazine MaleatePhase 21 trial
Continuous positive airway pressureN/A1 trial
Active Trials
NCT06145113Unknown75Est. Aug 2024
NCT06450899Completed57Est. Aug 2024
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
3 programs
Exposure to 3600 mN/A1 trial
Budesonide 200PHASE_11 trial
AcetazolamidePHASE_41 trial
Active Trials
NCT06499714Recruiting90Est. Dec 2025
NCT02811016Completed51Est. Oct 2016
NCT06499727Completed303Est. Aug 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Heidelberg PharmaAcetazolamide
Oregon TherapeuticsErythropoietin
Colorado TherapeuticsProchlorperazine Maleate
Heidelberg PharmaBudesonide 200
Heidelberg PharmaExposure to 3600 m
Colorado TherapeuticsContinuous positive airway pressure

Clinical Trials (6)

Total enrollment: 697 patients across 6 trials

NCT06499727Heidelberg PharmaAcetazolamide

HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to Men

Start: Jul 2024Est. completion: Aug 2025303 patients
Phase 4Completed
NCT05734716Oregon TherapeuticsErythropoietin

Colorado-Oregon Altitude Study

Start: Feb 2021Est. completion: Jan 2023121 patients
Phase 4Completed
NCT06450899Colorado TherapeuticsProchlorperazine Maleate

Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness

Start: Aug 2024Est. completion: Aug 202457 patients
Phase 2Completed
NCT02811016Heidelberg PharmaBudesonide 200

Inhaled Budesonide and Acute Mountain Sickness

Start: Jun 2016Est. completion: Oct 201651 patients
Phase 1Completed
NCT06499714Heidelberg PharmaExposure to 3600 m

HighCycle Study: Effect of High Altitude on Acute Mountain Sickness in Women Related to Their Menstrual Cycle Phase

Start: Jul 2024Est. completion: Dec 202590 patients
N/ARecruiting
NCT06145113Colorado TherapeuticsContinuous positive airway pressure

The Effect of Continuous Positive Pressure Ventilation on Symptoms of Acute Mountain Sickness

Start: Mar 2024Est. completion: Aug 202475 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 697 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.